Maria Angelica Cortez
Maria Angelica Cortez
Assistant Professor, The University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
MicroRNAs in body fluids—the mix of hormones and biomarkers
MA Cortez, C Bueso-Ramos, J Ferdin, G Lopez-Berestein, AK Sood, ...
Nature reviews Clinical oncology 8 (8), 467, 2011
12392011
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
L Chen, DL Gibbons, S Goswami, MA Cortez, YH Ahn, LA Byers, X Zhang, ...
Nature communications 5 (1), 1-12, 2014
5132014
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
MA Cortez, GA Calin
Expert opinion on biological therapy 9 (6), 703-711, 2009
4492009
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
Cancer discovery 5 (8), 860-877, 2015
3402015
PDL1 Regulation by p53 via miR-34
MA Cortez, C Ivan, D Valdecanas, X Wang, HJ Peltier, Y Ye, L Araujo, ...
JNCI: Journal of the National Cancer Institute 108 (1), 2016
3022016
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
C Tang, X Wang, H Soh, S Seyedin, MA Cortez, S Krishnan, E Massarelli, ...
Cancer immunology research 2 (9), 831-838, 2014
2222014
Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas
AKB Lucio-Eterovic, MAA Cortez, ET Valera, FJN Motta, RGP Queiroz, ...
BMC cancer 8 (1), 1-10, 2008
1692008
Cabozantinib overcomes crizotinib resistance in ROS1 fusion–positive cancer
R Katayama, Y Kobayashi, L Friboulet, EL Lockerman, S Koike, AT Shaw, ...
Clinical cancer research 21 (1), 166-174, 2015
1582015
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
DA Moreno, CA Scrideli, MAA Cortez, R de Paula Queiroz, ET Valera, ...
British journal of haematology 150 (6), 665-673, 2010
1572010
Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time …
CA Scrideli, CG Carlotti, OK Okamoto, VS Andrade, MAA Cortez, ...
Journal of neuro-oncology 88 (3), 281-291, 2008
1492008
miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma
MA Cortez, MS Nicoloso, M Shimizu, S Rossi, G Gopisetty, JR Molina, ...
Genes, Chromosomes and Cancer 49 (11), 981-990, 2010
1482010
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer
MA Cortez, D Valdecanas, X Zhang, Y Zhan, V Bhardwaj, GA Calin, ...
Molecular Therapy 22 (8), 1494-1503, 2014
1382014
Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy
X Wang, JE Schoenhals, A Li, DR Valdecanas, H Ye, F Zang, C Tang, ...
Cancer research 77 (4), 839-850, 2017
1132017
Circulating microRNAs as noninvasive biomarkers in breast cancer
MA Cortez, JW Welsh, GA Calin
Minimal residual disease and circulating tumor cells in breast cancer, 151-161, 2012
942012
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts
J Ferdin, N Nishida, X Wu, MS Nicoloso, MY Shah, C Devlin, H Ling, ...
Cell Death & Differentiation 20 (12), 1675-1687, 2013
832013
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov …
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
J Clin Invest 122 (12), 4388-400, 2012
712012
Strategies for combining immunotherapy with radiation for anticancer therapy
SN Seyedin, JE Schoenhals, DA Lee, MA Cortez, X Wang, S Niknam, ...
Immunotherapy 7 (9), 967-980, 2015
702015
microRNAs in cancer: from bench to bedside
MA Cortez, C Ivan, P Zhou, X Wu, M Ivan, GA Calin
Advances in cancer research 108, 113-157, 2010
532010
A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor …
CA Scrideli, JG Assumpção, MA Ganazza, M Araújo, SR Toledo, ...
haematologica 94 (6), 781-789, 2009
522009
Modulation of c‐Met signaling and cellular sensitivity to radiation: Potential implications for therapy
V Bhardwaj, T Cascone, MA Cortez, A Amini, J Evans, RU Komaki, ...
Cancer 119 (10), 1768-1775, 2013
492013
The system can't perform the operation now. Try again later.
Articles 1–20